Orphan Drugs in Asia Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market 2011

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Korean Drug Co Ltd

Korean Drug Co Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 56 pages

A textual analysis of the financial results for Korean Drug Co Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Drug and Medication | Countries: South Korea

South Korea Hyperbaric Oxygen Chambers Market Outlook to 2020

South Korea Hyperbaric Oxygen Chambers Market Outlook to 2020

  • $ 2 500
  • Industry report
  • by Global Data
  • October 2014
  • 24 pages

South Korea Hyperbaric Oxygen Chambers Market Outlook to 2020 Summary GlobalData's new report, "South Korea Hyperbaric Oxygen Chambers Market Outlook to 2020", provides key market data on the South Korea Hyperbaric Oxygen Chambers market. The report provides value, in millions of US dollars, volume (in ...

Industries: Drug and Medication | Countries: South Korea

Hiran Orgochem Ltd. (Symbol:506170) SWOT Analysis, Strategy, Revenues and Profits

Hiran Orgochem Ltd. (Symbol:506170) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Hiran Orgochem Ltd. SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: Philippines, Asia, Singapore, Indonesia, Bangladesh, Yemen, Vietnam, South Korea, Pakistan, Malaysia, Jordan, Japan, Israel, India

Ildong Pharmaceutical Co., Ltd. (Symbol:000230) SWOT Analysis, Strategy, Revenues and Profits

Ildong Pharmaceutical Co., Ltd. (Symbol:000230) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Ildong Pharmaceutical Co., Ltd. SWOT Analysis report provides you ...

Industries: Drug and Medication | Countries: South Korea

PharmswellBio Co., Ltd. (Symbol:043090) SWOT Analysis, Strategy, Revenues and Profits

PharmswellBio Co., Ltd. (Symbol:043090) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. PharmswellBio Co., Ltd. SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: South Korea

CMG Pharmaceutical Co., Ltd. (058820) - Financial and Strategic SWOT Analysis Review

CMG Pharmaceutical Co., Ltd. (058820) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

Summary CMG Pharmaceutical Co., Ltd. (CMG Pharmaceutical) is a pharmaceutical company, based in Korea. The company manufactures and sells pharmaceutical, health food and non-pharmaceutical products. It operates through product segments such as over-the-counter drugs and prescription drugs. CMG Pharmaceutical ...

Industries: Drug and Medication | Countries: South Korea

DAE HWA Pharmaceutical Co., Ltd. (067080) - Financial and Strategic SWOT Analysis Review

DAE HWA Pharmaceutical Co., Ltd. (067080) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

Summary DAE HWA Pharmaceutical Co., Ltd. (DAE HWA) is a specialized pharmaceutical company. It conducts the research and manufacture of prescription and over-the-counter (OTC) finished pharmaceutical products. The company also manufactures APIs.These drugs are aimed at the prevention and treatment of ...

Industries: Drug and Medication | Countries: South Korea

JW Pharmaceutical Corporation (001060) - Financial and Strategic SWOT Analysis Review

JW Pharmaceutical Corporation (001060) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

Summary JW Pharmaceutical Corporation (JW Pharmaceutical) is a pharmaceutical company. The company develops, produces and markets analgesics, antipyretics and cold remedy, antidote agents, antimicrobials, anticancer agents, antifungal agents, cardiovascular agents, gastrointestinla agents, miscellaneous, ...

Industries: Drug and Medication | Countries: South Korea

Hepahope Korea, Inc. (Symbol:039350) SWOT Analysis, Strategy, Revenues and Profits

Hepahope Korea, Inc. (Symbol:039350) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Hepahope Korea, Inc. SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: South Korea

Myungmoon pharmaceutical Co.,Ltd. (Symbol:017180) SWOT Analysis, Strategy, Revenues and Profits

Myungmoon pharmaceutical Co.,Ltd. (Symbol:017180) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Myungmoon pharmaceutical Co.,Ltd. SWOT Analysis report provides you ...

Industries: Drug and Medication | Countries: South Korea

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.